GUANGZHI QU, M.D.
Hematology & Oncology Physician · JACKSON, MS
Individual Active NPI 1790780716
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,208 | 647,096 | $46,258,147 | $15,457,463 | $12,351,361 |
| 2023 | 1,242 | 801,310 | $57,090,851 | $17,198,309 | $13,712,096 |
| 2022 | 1,085 | 812,581 | $45,017,882 | $13,737,105 | $10,968,791 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9299 | Injection, nivolumab, 1 mg | 60,040 | $30 | $24 |
| J9271 | Injection, pembrolizumab, 1 mg | 43,800 | $53 | $42 |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 32,830 | $46 | $37 |
| J0185 | Injection, aprepitant, 1 mg | 28,730 | $2 | $1 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 26,250 | $1 | $1 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 24,552 | $25 | $20 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 24,300 | $47 | $38 |
| J0897 | Injection, denosumab, 1 mg | 18,900 | $25 | $20 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 18,600 | $0 | $0 |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 16,500 | $13 | $11 |
| J9041 | Injection, bortezomib, 0.1 mg | 10,080 | $2 | $1 |
| J9267 | Injection, paclitaxel, 1 mg | 9,540 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 18238 | MS |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Mississippi
- NPI 1104862259
- NPI 1245212844
- NPI 1801250626
- NPI 1538322011
- NPI 1528167541
- NPI 1912901513
- NPI 1003026345
- NPI 1295776136
See all Hematology & Oncology Physician providers in Mississippi →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.